《Table 1.Bone diseases or dysfunctions caused by glutamate GPCR mutation or deletion》

《Table 1.Bone diseases or dysfunctions caused by glutamate GPCR mutation or deletion》   提示:宽带有限、当前游客访问压缩模式
本系列图表出处文件名:随高清版一同展现
《The role of GPCRs in bone diseases and dysfunctions》


  1. 获取 高清版本忘记账户?点击这里登录
  1. 下载图表忘记账户?点击这里登录

Furthermore,several GPCR gene knockout mice displayed different phenotypes in different strains.The bone mass was reduced in young(4-week-old)P2y13-knockout mice via promotion of osteoblastogenesis and suppression of osteoclastogenesis,but mature(>10-week-old)P2y13-knockout mice showed the opposite bone phenotype via suppression of osteoblastogenesis.229,231P2y2 deficiency increased mouse bone mass in C57BL/6mice225,232by promoting bone reformation and suppressing bone resorption but exhibited reduced bone mass in SV129 mice233by reducing osteoblast differentiation and mineralization.P2y7knockout reduced bone mass in mixed genetic mice(129/OlaXC57BL/6XDBA/2)by reducing osteoblast number and activity234but increased cortical thickness in C57 mice235promoting osteoclast-mediated bone resorption(Table 5).